389 related articles for article (PubMed ID: 34836413)
1. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review.
Keeler JL; Treasure J; Juruena MF; Kan C; Himmerich H
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836413
[TBL] [Abstract][Full Text] [Related]
2. Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine : a case report.
Timek A; Daniels-Brady C; Ferrando S
J Eat Disord; 2024 Jun; 12(1):79. PubMed ID: 38867336
[TBL] [Abstract][Full Text] [Related]
3. Anorexia nervosa, zinc deficiency and the glutamate system: The ketamine option.
Hermens DF; Simcock G; Dutton M; Bouças AP; Can AT; Lilley C; Lagopoulos J
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109921. PubMed ID: 32169564
[TBL] [Abstract][Full Text] [Related]
4. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
5. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.
Abdallah CG; Sanacora G; Duman RS; Krystal JH
Annu Rev Med; 2015; 66():509-23. PubMed ID: 25341010
[TBL] [Abstract][Full Text] [Related]
6. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.
Dean RL; Hurducas C; Hawton K; Spyridi S; Cowen PJ; Hollingsworth S; Marquardt T; Barnes A; Smith R; McShane R; Turner EH; Cipriani A
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011612. PubMed ID: 34510411
[TBL] [Abstract][Full Text] [Related]
7. Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation.
Mitchell JS; Hermens DF; Bennett MR; Can AT; Lagopoulos J
CNS Drugs; 2023 Feb; 37(2):159-180. PubMed ID: 36681939
[TBL] [Abstract][Full Text] [Related]
8. [Antidepressants sometimes lead to rapid remission in the treatment of anorexia nervosa].
Tury F; Mezei A; Szenyei G; Rihmer Z
Neuropsychopharmacol Hung; 2020 Jun; 22(2):72-76. PubMed ID: 32683331
[TBL] [Abstract][Full Text] [Related]
9. Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.
Krystal JH; Sanacora G; Duman RS
Biol Psychiatry; 2013 Jun; 73(12):1133-41. PubMed ID: 23726151
[TBL] [Abstract][Full Text] [Related]
10. [Comorbid major depressive disorder of anorexia nervosa in adolescence: A scoping review of treatment strategies].
Carretier E; Blanchet C; Moro MR; Lachal J
Encephale; 2021 Feb; 47(1):72-78. PubMed ID: 32933763
[TBL] [Abstract][Full Text] [Related]
11. Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study.
Calabrese L; Scolnick B; Zupec-Kania B; Beckwith C; Costello K; Frank GKW
Eat Weight Disord; 2022 Dec; 27(8):3751-3757. PubMed ID: 35997954
[TBL] [Abstract][Full Text] [Related]
12. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
McIntyre RS; Rosenblat JD; Nemeroff CB; Sanacora G; Murrough JW; Berk M; Brietzke E; Dodd S; Gorwood P; Ho R; Iosifescu DV; Lopez Jaramillo C; Kasper S; Kratiuk K; Lee JG; Lee Y; Lui LMW; Mansur RB; Papakostas GI; Subramaniapillai M; Thase M; Vieta E; Young AH; Zarate CA; Stahl S
Am J Psychiatry; 2021 May; 178(5):383-399. PubMed ID: 33726522
[TBL] [Abstract][Full Text] [Related]
13. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine's Antidepressant Effect.
Cui W; Ning Y; Hong W; Wang J; Liu Z; Li MD
Mol Neurobiol; 2019 May; 56(5):3484-3500. PubMed ID: 30140973
[TBL] [Abstract][Full Text] [Related]
15. Guanosine as a promising target for fast-acting antidepressant responses.
Camargo A; Rodrigues ALS
Pharmacol Biochem Behav; 2022 Jul; 218():173422. PubMed ID: 35732211
[TBL] [Abstract][Full Text] [Related]
16. Treatment of anorexia nervosa with antidepressants.
Hudson JI; Pope HG; Jonas JM; Yurgelun-Todd D
J Clin Psychopharmacol; 1985 Feb; 5(1):17-23. PubMed ID: 3919068
[TBL] [Abstract][Full Text] [Related]
17. Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications.
Zhang MW; Harris KM; Ho RC
BMC Med Ethics; 2016 Jan; 17():4. PubMed ID: 26768892
[TBL] [Abstract][Full Text] [Related]
18. Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?
d'Andrea G; Pettorruso M; Lorenzo GD; Mancusi G; McIntyre RS; Martinotti G
Eur Neuropsychopharmacol; 2023 May; 70():49-55. PubMed ID: 36867895
[TBL] [Abstract][Full Text] [Related]
19. Toward specific ways to combine ketamine and psychotherapy in treating depression.
Hasler G
CNS Spectr; 2020 Jun; 25(3):445-447. PubMed ID: 31213212
[TBL] [Abstract][Full Text] [Related]
20. Medications in the treatment of eating disorders.
Jimerson DC; Wolfe BE; Brotman AW; Metzger ED
Psychiatr Clin North Am; 1996 Dec; 19(4):739-54. PubMed ID: 8933605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
